We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+24.53%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$7.44B
AUM Growth
+$2.18B
Cap. Flow
+$1.12B
Cap. Flow %
15.11%
Top 10 Hldgs %
13.07%
Holding
2,045
New
726
Increased
371
Reduced
415
Closed
520

Sector Composition

Rank Sector Weight
1 Financials 19.3%
2 Technology 16.73%
3 Consumer Discretionary 13.16%
4 Industrials 8.74%
5 Healthcare 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAND
1151
DELISTED
Sandstorm Gold
SAND
$355K ﹤0.01%
+49,500
New +$383K
BREZ
1152
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$355K ﹤0.01%
+35,000
New +$357K
CHA
1153
DELISTED
China Telecom Corporation, LTD
CHA
$355K ﹤0.01%
+12,900
New +$395K
RNST icon
1154
Renasant Corp
RNST
$3.96B
$353K ﹤0.01%
+10,500
New +$321K
CFACU
1155
DELISTED
CF Finance Acquisition Corp. III Unit
CFACU
$349K ﹤0.01%
+32,500
New +$335K
G icon
1156
Genpact
G
$6.13B
$348K ﹤0.01%
8,400
-142,159
-94% -$5.62M
ONCT
1157
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$347K ﹤0.01%
+3,540
New +$224K
SOXL icon
1158
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$22.4B
$343K ﹤0.01%
+11,025
New +$264K
L icon
1159
Loews
L
$23.7B
$342K ﹤0.01%
+7,599
New +$305K
BHSEU
1160
DELISTED
Bull Horn Holdings Corp. Unit
BHSEU
$341K ﹤0.01%
+30,000
New +$304K
BMY.RT
1161
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$341K ﹤0.01%
493,006
-598,243
-55% -$1.27M
MOG.A icon
1162
Moog Inc Class A
MOG.A
$13B
$338K ﹤0.01%
+4,269
New +$313K
HNI icon
1163
HNI Corp
HNI
$3.53B
$337K ﹤0.01%
+9,800
New +$352K
INMD icon
1164
InMode
INMD
$869M
$337K ﹤0.01%
14,200
-13,600
-49% -$287K
GOTU icon
1165
Gaotu Techedu
GOTU
$453M
$336K ﹤0.01%
6,500
-10,337
-61% -$754K
LEN icon
1166
Lennar Class A
LEN
$20.4B
$336K ﹤0.01%
+4,545
New +$340K
DXC icon
1167
DXC Technology
DXC
$1.77B
$335K ﹤0.01%
13,011
+484
+4% +$10.3K
LAC
1168
DELISTED
Lithium Americas Corp. Common Shares
LAC
$335K ﹤0.01%
+26,700
New +$300K
KXIN icon
1169
Kaixin Holdings
KXIN
$9M
0
NDSN icon
1170
Nordson
NDSN
$17.2B
$334K ﹤0.01%
+1,660
New +$333K
VRNA
1171
DELISTED
Verona Pharma
VRNA
$334K ﹤0.01%
47,800
-6,800
-12% -$45.9K
DEA
1172
Easterly Government Properties
DEA
$1.18B
$333K ﹤0.01%
+5,880
New +$323K
BSY icon
1173
Bentley Systems
BSY
$10.7B
$332K ﹤0.01%
8,200
-986
-11% -$35K
DRNA
1174
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$330K ﹤0.01%
14,938
-44,806
-75% -$987K
BKH icon
1175
Black Hills Corp
BKH
$5.54B
$329K ﹤0.01%
5,358
-2,142
-29% -$128K

Similar funds

Schonfeld Strategic Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Schonfeld Strategic Advisors held 2,045 positions worth $7.44B, up 42% from $5.25B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $1.12B of net new capital in Q4 2020, opening 726 new positions and adding to 371 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 272,911 shares worth $102M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Crown Holdings, an estimated $43.8M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 272,911 shares worth $102M.
  • Schonfeld Strategic Advisors added most to US Bancorp in Q4 2020, an estimated $62.4M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2020 reduction was Crown Holdings, cutting an estimated $43.8M.
  • Schonfeld Strategic Advisors fully exited Claritev Corp in Q4 2020, selling an estimated $30.8M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $7.44B portfolio in Q4 2020.
  • Schonfeld Strategic Advisors opened 726 new positions and closed 520 in Q4 2020.
  • Schonfeld Strategic Advisors's portfolio value rose 42% quarter-over-quarter to $7.44B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.